Molecular formula:C194H312N54O59S2
Molecular weight: 4408.258
Patent period: —
Dositive specifications:–
Injection: 1–
Oral tablets: —
Injection : —
Molecular formula:C194H312N54O59S2
Molecular weight: 4408.258
Patent period: —
Dositive specifications:–
Injection: 1–
Oral tablets: —
Injection : —
Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity.
ACTIONS | — |
---|---|
CAS NO. | 1415456-99-3 |
FORMULA | C194H312N54O59S2 |
M. WT | 4408.258 |
PURITY | — |
SYNONYMS | 0 |
STORAGE | — |